Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.3 - $0.57 $8,610 - $16,358
28,700 New
28,700 $10,000
Q4 2022

Feb 13, 2023

SELL
$0.55 - $17.1 $349,285 - $10.9 Million
-635,065 Reduced 60.74%
410,461 $259,000
Q3 2022

Nov 14, 2022

BUY
$0.4 - $58.5 $257,558 - $37.7 Million
643,897 Added 160.32%
1,045,526 $1.14 Million
Q2 2022

Aug 12, 2022

BUY
$9.29 - $34.8 $3.73 Million - $14 Million
401,629 New
401,629 $333,000

About GeoVax Labs, Inc.


  • Ticker GOVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,744,000
  • Market Cap $55.9M
  • Description
  • GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...
More about GOVX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.